LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 12

Search options

  1. Article ; Online: SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.

    Meylan, Sylvain / Dafni, Urania / Lamoth, Frederic / Tsourti, Zoi / Lobritz, Michael A / Regina, Jean / Bressin, Philippe / Senn, Laurence / Grandbastien, Bruno / Andre, Cyril / Fenwick, Craig / D'Acremont, Valerie / Croxatto, Antony / Guilleret, Isabelle / Greub, Gilbert / Manuel, Oriol / Calandra, Thierry / Pantaleo, Giuseppe / Lazor-Blanchet, Catherine

    BMJ open

    2021  Volume 11, Issue 7, Page(s) e049232

    Abstract: Objective: To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure.: Design: Seroprevalence cross-sectional study.: Setting: ... ...

    Abstract Objective: To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure.
    Design: Seroprevalence cross-sectional study.
    Setting: Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland.
    Participants: 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs.
    Main outcome measures: Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisition risk factors internal and external to the workplace.
    Results: The overall SARS-CoV-2 seroprevalence rate among HCWs was 10.0% (95% CI 8.7% to 11.5%). HCWs with daily patient contact did not experience increased rates of seropositivity relative to those without (10.3% vs 9.6%, respectively, p=0.64). HCWs with direct contact with patients with COVID-19 or working in COVID-19 units did not experience increased seropositivity rates relative to their counterparts (10.4% vs 9.8%, p=0.69 and 10.6% vs 9.9%, p=0.69, respectively). However, specific locations of contact with patients irrespective of COVID-19 status-in patient rooms or reception areas-did correlate with increased rates of seropositivity (11.9% vs 7.5%, p=0.019 and 14.3% vs 9.2%, p=0.025, respectively). In contrast, HCWs with a suspected or proven SARS-CoV-2-infected household contact had significantly higher seropositivity rates than those without such contacts (19.0% vs 8.7%, p<0.001 and 42.1% vs 9.4%, p<0.001, respectively). Finally, consistent use of a mask on public transportation correlated with decreased seroprevalence (5.3% for mask users vs 11.2% for intermittent or no mask use, p=0.030).
    Conclusions: The overall seroprevalence was 10% without significant differences in seroprevalence between HCWs exposed to patients with COVID-19 and HCWs not exposed. This suggests that, once fully in place, protective measures limited SARS-CoV-2 occupational acquisition within the hospital environment. SARS-CoV-2 seroconversion among HCWs was associated primarily with community risk factors, particularly household transmission.
    MeSH term(s) COVID-19 ; Cross-Sectional Studies ; Health Personnel ; Humans ; SARS-CoV-2 ; Seroepidemiologic Studies ; Switzerland/epidemiology ; Tertiary Care Centers
    Language English
    Publishing date 2021-07-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2021-049232
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.

    Guilleret, Isabelle / Benhattar, Jean

    Biochemical and biophysical research communications

    2004  Volume 325, Issue 3, Page(s) 1037–1043

    Abstract: The promoter region of the gene encoding the human telomerase reverse transcriptase (hTERT) is located in a CpG island and was shown to be regulated, at least in part, by DNA methylation. However, the observed correlation between hTERT methylation and ... ...

    Abstract The promoter region of the gene encoding the human telomerase reverse transcriptase (hTERT) is located in a CpG island and was shown to be regulated, at least in part, by DNA methylation. However, the observed correlation between hTERT methylation and gene expression was opposite to the general model of regulation by DNA methylation. We established a detailed mapping of methylcytosines at the CpG island (-1539 to +1732) surrounding the hTERT promoter in tissues and cell lines. In telomerase-positive samples, a methylation of all the CpG sites was observed for the hTERT promoter region (-500 to +1), whereas the exonic part (+1 to +450) revealed an unstable methylation pattern. Incomplete methylation of the proximal exon region could be necessary for, at least, a low level of hTERT transcription. In conclusion, hypermethylation of the CpG island plays a complex but essential role in the expression of hTERT in telomerase-positive cells.
    MeSH term(s) Cell Line, Tumor ; CpG Islands/genetics ; DNA Methylation ; DNA-Binding Proteins ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Neoplasms/genetics ; Organ Specificity ; Promoter Regions, Genetic/genetics ; Sequence Analysis, DNA/methods ; Sequence Homology, Nucleic Acid ; Telomerase/genetics
    Chemical Substances DNA-Binding Proteins ; Telomerase (EC 2.7.7.49)
    Language English
    Publishing date 2004-12-17
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 205723-2
    ISSN 0006-291X ; 0006-291X
    ISSN (online) 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2004.10.137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.

    Guilleret, Isabelle / Benhattar, Jean

    Experimental cell research

    2003  Volume 289, Issue 2, Page(s) 326–334

    Abstract: Telomerase is the ribonucleoproteic complex involved in maintaining telomere size. It is expressed in germ and stem cells but not in normal somatic cells. In most tumors, telomerase is reactivated. In humans, telomerase activity is tightly regulated by ... ...

    Abstract Telomerase is the ribonucleoproteic complex involved in maintaining telomere size. It is expressed in germ and stem cells but not in normal somatic cells. In most tumors, telomerase is reactivated. In humans, telomerase activity is tightly regulated by expression of the hTERT gene. In a previous study, we found a direct correlation between methylation of the hTERT promoter and hTERT gene expression. In order to demonstrate this correlation, demethylation experiments were performed with the demethylating agent 5aza-2'-deoxycytidine (5azadC). Three telomerase-positive tumor cell lines (Lan-1, HeLa, and Co115), presenting a hypermethylated hTERT promoter, were treated with different doses and types of treatment for a long period. Analysis of methylation revealed a final hTERT promoter demethylation up to 95%. Quantification of hTERT mRNA showed that transcription was strongly repressed during drug exposure. In contrast, expression of c-Myc, an activator of hTERT promoter, was barely down-regulated or increased by the treatment. Using a TRAP assay, telomerase activity was semiquantified in all experiments. It strongly decreased or was suppressed after two to four passages. Finally, telomere length was measured by Southern blot. Their averages were not modified, but ranges concentrated around the mean. Thus, it is likely that hTERT promoter hypermethylation would be necessary for its expression.
    MeSH term(s) Antimetabolites, Antineoplastic/pharmacology ; Azacitidine/analogs & derivatives ; Azacitidine/pharmacology ; Cell Division/drug effects ; Cell Division/genetics ; Cellular Senescence/drug effects ; Cellular Senescence/genetics ; DNA Methylation/drug effects ; DNA-Binding Proteins ; Decitabine ; Down-Regulation/drug effects ; Down-Regulation/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Neoplasms/enzymology ; Neoplasms/genetics ; Promoter Regions, Genetic/drug effects ; Promoter Regions, Genetic/genetics ; Proto-Oncogene Proteins c-myc/drug effects ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; RNA, Messenger/drug effects ; RNA, Messenger/metabolism ; Telomerase/drug effects ; Telomerase/genetics ; Telomerase/metabolism ; Telomere/drug effects ; Telomere/genetics ; Telomere/metabolism ; Transcription, Genetic/drug effects ; Transcription, Genetic/genetics ; Tumor Cells, Cultured
    Chemical Substances Antimetabolites, Antineoplastic ; DNA-Binding Proteins ; Proto-Oncogene Proteins c-myc ; RNA, Messenger ; Decitabine (776B62CQ27) ; Telomerase (EC 2.7.7.49) ; Azacitidine (M801H13NRU)
    Language English
    Publishing date 2003-10-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1493-x
    ISSN 1090-2422 ; 0014-4827
    ISSN (online) 1090-2422
    ISSN 0014-4827
    DOI 10.1016/s0014-4827(03)00281-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM)

    Guilleret, Isabelle / Lorena Losi / Sonia T. Chelbi / Sergio Fonda / Stéphanie Bougel / Sara Saponaro / Gaia Gozzi / Loredana Alberti / Richard Braunschweig / Jean Benhattar

    Biochemical and biophysical research communications. 2016 Oct. 14, v. 479

    2016  

    Abstract: Most types of cancer cells are characterized by aberrant methylation of promoter genes. In this study, we described a rapid, reproducible, and relatively inexpensive approach allowing the detection of multiple human methylated promoter genes from many ... ...

    Abstract Most types of cancer cells are characterized by aberrant methylation of promoter genes. In this study, we described a rapid, reproducible, and relatively inexpensive approach allowing the detection of multiple human methylated promoter genes from many tissue samples, without the need of bisulfite conversion. The Methylation Ligation-dependent Macroarray (MLM), an array-based analysis, was designed in order to measure methylation levels of 58 genes previously described as putative biomarkers of cancer. The performance of the design was proven by screening the methylation profile of DNA from esophageal cell lines, as well as microdissected formalin-fixed and paraffin-embedded (FFPE) tissues from esophageal adenocarcinoma (EAC). Using the MLM approach, we identified 32 (55%) hypermethylated promoters in EAC, and not or rarely methylated in normal tissues. Among them, 21promoters were found aberrantly methylated in more than half of tumors. Moreover, seven of them (ADAMTS18, APC, DKK2, FOXL2, GPX3, TIMP3 and WIF1) were found aberrantly methylated in all or almost all the tumor samples, suggesting an important role for these genes in EAC. In addition, dysregulation of the Wnt pathway with hypermethylation of several Wnt antagonist genes was frequently observed. MLM revealed a homogeneous pattern of methylation for a majority of tumors which were associated with an advanced stage at presentation and a poor prognosis. Interestingly, the few tumors presenting less methylation changes had a lower pathological stage. In conclusion, this study demonstrated the feasibility and accuracy of MLM for DNA methylation profiling of FFPE tissue samples.
    Keywords DNA ; DNA methylation ; adenocarcinoma ; antagonists ; biomarkers ; genes ; humans ; neoplasm cells ; prognosis ; screening ; tissues
    Language English
    Dates of publication 2016-1014
    Size p. 231-237.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 205723-2
    ISSN 0006-291X ; 0006-291X
    ISSN (online) 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2016.09.049
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Bicc1 links the regulation of cAMP signaling in polycystic kidneys to microRNA-induced gene silencing.

    Piazzon, Nathalie / Maisonneuve, Charlotte / Guilleret, Isabelle / Rotman, Samuel / Constam, Daniel B

    Journal of molecular cell biology

    2012  Volume 4, Issue 6, Page(s) 398–408

    Abstract: Genetic defects in autosomal-dominant polycystic kidney disease (ADPKD) promote cystic growth of renal tubules, at least in part by stimulating the accumulation of cAMP. How renal cAMP levels are regulated is incompletely understood. We show that cAMP ... ...

    Abstract Genetic defects in autosomal-dominant polycystic kidney disease (ADPKD) promote cystic growth of renal tubules, at least in part by stimulating the accumulation of cAMP. How renal cAMP levels are regulated is incompletely understood. We show that cAMP and the expression of its synthetic enzyme adenylate cyclase-6 (AC6) are up-regulated in cystic kidneys of Bicc1(-)(/-) knockout mice. Bicc1, a protein comprising three K homology (KH) domains and a sterile alpha motif (SAM), is expressed in proximal tubules. The KH domains independently bind AC6 mRNA and recruit the miR-125a from Dicer, whereas the SAM domain enables silencing by Argonaute and TNRC6A/GW182. Bicc1 similarly induces silencing of the protein kinase inhibitor PKIα by miR-27a. Thus, Bicc1 is needed on these target mRNAs for silencing by specific miRNAs. The repression of AC6 by Bicc1 might explain why cysts in ADPKD patients preferentially arise from distal tubules.
    MeSH term(s) 3' Untranslated Regions/genetics ; Adenylyl Cyclases/genetics ; Adenylyl Cyclases/metabolism ; Animals ; Argonaute Proteins/genetics ; Argonaute Proteins/metabolism ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Cell Line ; Cyclic AMP/genetics ; Cyclic AMP/metabolism ; Gene Silencing/physiology ; HEK293 Cells ; Humans ; Intracellular Signaling Peptides and Proteins/genetics ; Intracellular Signaling Peptides and Proteins/metabolism ; Kidney Tubules/metabolism ; Kidney Tubules/physiopathology ; Mice ; Mice, Inbred C57BL ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Polycystic Kidney Diseases/metabolism ; Polycystic Kidney Diseases/physiopathology ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism ; Signal Transduction/genetics ; Signal Transduction/physiology
    Chemical Substances 3' Untranslated Regions ; Argonaute Proteins ; Bicc1 protein, mouse ; Carrier Proteins ; EIF2C2 protein, mouse ; Intracellular Signaling Peptides and Proteins ; MicroRNAs ; Mirn125 microRNA, mouse ; Pkia protein, mouse ; RNA, Messenger ; RNA-Binding Proteins ; Cyclic AMP (E0399OZS9N) ; Adenylyl Cyclases (EC 4.6.1.1) ; adenylyl cyclase 6 (EC 4.6.1.1)
    Language English
    Publishing date 2012-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2500949-7
    ISSN 1759-4685 ; 1674-2788
    ISSN (online) 1759-4685
    ISSN 1674-2788
    DOI 10.1093/jmcb/mjs027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia - a proof-of-concept study.

    Maurer, Fabienne / Pradervand, Sylvain / Guilleret, Isabelle / Nanchen, David / Maghraoui, Ali / Chapatte, Laurence / Bojkowska, Karolina / Bhuiyan, Zahurul Alam / Jacquemont, Nathalie / Harshman, Keith / Mooser, Vincent

    Swiss medical weekly

    2016  Volume 146, Page(s) w14326

    Abstract: Aims: We aimed to identify familial hypercholesterolaemia mutation carriers among participants to the Lausanne Institutional Biobank (BIL). Our experimental workflow was designed as a proof-of-concept demonstration of the resources and services provided ...

    Abstract Aims: We aimed to identify familial hypercholesterolaemia mutation carriers among participants to the Lausanne Institutional Biobank (BIL). Our experimental workflow was designed as a proof-of-concept demonstration of the resources and services provided by our integrated institutional clinical research support platform.
    Methods: Familial hypercholesterolaemia was used as a model of a relatively common yet often underdiagnosed and inadequately treated Mendelian disease. Clinical and laboratory information was extracted from electronic hospital records. Patients were selected using elevated plasma cholesterol levels (total cholesterol ≥7.5 mM or low-density lipoprotein cholesterol ≥5 mM), premature coronary artery disease status and age (18-60 yr) as main inclusion criteria. LDLR, APOB and PCSK9 were analysed by high-throughput DNA sequencing. The most relevant mutations were confirmed by Sanger sequencing.
    Results: Of 23 737 patients contacted by the BIL, 17 760 individuals consented to participate and 13 094 wished to be recontacted if there were findings requiring clinical action. Plasma cholesterol records were available for 5111 participants, of whom 94 were selected for genetic screening. Twenty-five of the tested patients presented with premature coronary artery disease while 69 had no such diagnosis. Seven heterozygous carriers of eight rare coding missense variants were identified. Three mutations were pathogenic (APOB p.R3527Q) or likely pathogenic (LDLR p.C27W, LDLR p.P526S) for hypercholesterolaemia, while the others were either benign or of unknown significance. One patient was a double heterozygote for variants APOB p.R3527Q and LDLR p.P526S.
    Conclusion: This work illustrates how clinical and translational research can benefit from a dedicated platform integrating both a hospital-based biobank and a data support team.
    MeSH term(s) Adolescent ; Adult ; Apolipoproteins B/genetics ; Biological Specimen Banks ; Cholesterol/blood ; Cholesterol, LDL/blood ; Coronary Artery Disease/epidemiology ; Female ; Humans ; Hyperlipoproteinemia Type II/blood ; Hyperlipoproteinemia Type II/genetics ; Male ; Medical Records ; Middle Aged ; Mutation/genetics ; Polymerase Chain Reaction ; Proprotein Convertase 9/genetics ; Receptors, LDL/genetics ; Switzerland/epidemiology ; Young Adult
    Chemical Substances Apolipoproteins B ; Cholesterol, LDL ; LDLR protein, human ; Receptors, LDL ; Cholesterol (97C5T2UQ7J) ; PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-)
    Language English
    Publishing date 2016
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2036179-8
    ISSN 1424-3997 ; 1424-7860
    ISSN (online) 1424-3997
    ISSN 1424-7860
    DOI 10.4414/smw.2016.14326
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).

    Guilleret, Isabelle / Losi, Lorena / Chelbi, Sonia T / Fonda, Sergio / Bougel, Stéphanie / Saponaro, Sara / Gozzi, Gaia / Alberti, Loredana / Braunschweig, Richard / Benhattar, Jean

    Biochemical and biophysical research communications

    2016  Volume 479, Issue 2, Page(s) 231–237

    Abstract: Most types of cancer cells are characterized by aberrant methylation of promoter genes. In this study, we described a rapid, reproducible, and relatively inexpensive approach allowing the detection of multiple human methylated promoter genes from many ... ...

    Abstract Most types of cancer cells are characterized by aberrant methylation of promoter genes. In this study, we described a rapid, reproducible, and relatively inexpensive approach allowing the detection of multiple human methylated promoter genes from many tissue samples, without the need of bisulfite conversion. The Methylation Ligation-dependent Macroarray (MLM), an array-based analysis, was designed in order to measure methylation levels of 58 genes previously described as putative biomarkers of cancer. The performance of the design was proven by screening the methylation profile of DNA from esophageal cell lines, as well as microdissected formalin-fixed and paraffin-embedded (FFPE) tissues from esophageal adenocarcinoma (EAC). Using the MLM approach, we identified 32 (55%) hypermethylated promoters in EAC, and not or rarely methylated in normal tissues. Among them, 21promoters were found aberrantly methylated in more than half of tumors. Moreover, seven of them (ADAMTS18, APC, DKK2, FOXL2, GPX3, TIMP3 and WIF1) were found aberrantly methylated in all or almost all the tumor samples, suggesting an important role for these genes in EAC. In addition, dysregulation of the Wnt pathway with hypermethylation of several Wnt antagonist genes was frequently observed. MLM revealed a homogeneous pattern of methylation for a majority of tumors which were associated with an advanced stage at presentation and a poor prognosis. Interestingly, the few tumors presenting less methylation changes had a lower pathological stage. In conclusion, this study demonstrated the feasibility and accuracy of MLM for DNA methylation profiling of FFPE tissue samples.
    MeSH term(s) Adenocarcinoma/genetics ; Adenocarcinoma/pathology ; Biomarkers, Tumor/genetics ; Cell Line, Tumor ; DNA Methylation ; DNA, Neoplasm/chemistry ; DNA, Neoplasm/genetics ; Esophageal Neoplasms/genetics ; Esophageal Neoplasms/pathology ; Feasibility Studies ; Fixatives/chemistry ; Formaldehyde/chemistry ; Humans ; Microarray Analysis/methods ; Paraffin Embedding ; Polymerase Chain Reaction/methods ; Promoter Regions, Genetic/genetics ; Reproducibility of Results ; Sequence Analysis, DNA/methods ; Tissue Fixation ; Wnt Signaling Pathway/genetics
    Chemical Substances Biomarkers, Tumor ; DNA, Neoplasm ; Fixatives ; Formaldehyde (1HG84L3525)
    Language English
    Publishing date 2016-10-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2016.09.049
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Imprinting of tumor-suppressor genes in human placenta.

    Guilleret, Isabelle / Osterheld, Maria-Chiara / Braunschweig, Richard / Gastineau, Véronique / Taillens, Suzanne / Benhattar, Jean

    Epigenetics

    2009  Volume 4, Issue 1, Page(s) 62–68

    Abstract: Transcriptional deregulation in cancer has been shown to be associated with epigenetic alterations, in particular to tumor-suppressor- gene (TSG) promoters. In contrast, DNA methylation of TSGs is not considered to be present in normal differentiated ... ...

    Abstract Transcriptional deregulation in cancer has been shown to be associated with epigenetic alterations, in particular to tumor-suppressor- gene (TSG) promoters. In contrast, DNA methylation of TSGs is not considered to be present in normal differentiated cells. Nevertheless, we previously showed that the promoter of the tumor-suppressor gene APC is methylated, for one allele only, in normal gastric cells. Recently, RASSF1A has been shown to be imprinted in normal human placenta. To clarify putative TSG methylation in the placenta, 23 normal placental tissues from the first trimester, both decidua and villi, and four normal non-gestational endometrium were screened for DNA methylation by methylation-sensitive single-strand conformation analysis (MS-SSCA) and sequencing after bisulfite modification, on a panel of 12 genes known to be implicated in carcinogenesis. In all placental villi, four TSG promoters-APC, SFRP2, RASSF1A and WIF1-were hypermethylated, whereas all decidua and normal endometrium did not show any methylation. Allele-specific methylation analysis revealed that this methylation was monoallelic. Furthermore, comparison with maternal DNA indicated that APC and WIF1 were methylated on the maternal allele, whereas SFRP2 was methylated on the paternal allele. Sequence analysis of WIF1 mRNA revealed that only the unmethylated paternal allele was transcribed. The imprinting status of these TSGs is conserved during pregnancy. These results indicate that TSG imprinting is pre-existent in normal human placenta and should not be confused with carcinogenesis or pathology-induced methylation.
    MeSH term(s) Alleles ; DNA Methylation ; DNA Primers/genetics ; Endometrium/metabolism ; Epigenesis, Genetic ; Exons ; Female ; Genes, Tumor Suppressor ; Genomic Imprinting ; Humans ; Models, Genetic ; Placenta/metabolism ; Pregnancy ; Pregnancy Trimester, First ; Transcription, Genetic
    Chemical Substances DNA Primers
    Language English
    Publishing date 2009-01-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1559-2308
    ISSN (online) 1559-2308
    DOI 10.4161/epi.4.1.7471
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow.

    Maisonneuve, Charlotte / Guilleret, Isabelle / Vick, Philipp / Weber, Thomas / Andre, Philipp / Beyer, Tina / Blum, Martin / Constam, Daniel B

    Development (Cambridge, England)

    2009  Volume 136, Issue 17, Page(s) 3019–3030

    Abstract: Polycystic diseases and left-right (LR) axis malformations are frequently linked to cilia defects. Renal cysts also arise in mice and frogs lacking Bicaudal C (BicC), a conserved RNA-binding protein containing K-homology (KH) domains and a sterile alpha ... ...

    Abstract Polycystic diseases and left-right (LR) axis malformations are frequently linked to cilia defects. Renal cysts also arise in mice and frogs lacking Bicaudal C (BicC), a conserved RNA-binding protein containing K-homology (KH) domains and a sterile alpha motif (SAM). However, a role for BicC in cilia function has not been demonstrated. Here, we report that targeted inactivation of BicC randomizes left-right (LR) asymmetry by disrupting the planar alignment of motile cilia required for cilia-driven fluid flow. Furthermore, depending on its SAM domain, BicC can uncouple Dvl2 signaling from the canonical Wnt pathway, which has been implicated in antagonizing planar cell polarity (PCP). The SAM domain concentrates BicC in cytoplasmic structures harboring RNA-processing bodies (P-bodies) and Dvl2. These results suggest a model whereby BicC links the orientation of cilia with PCP, possibly by regulating RNA silencing in P-bodies.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Animals ; Body Patterning/physiology ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Cell Line ; Cell Polarity ; Cilia/metabolism ; Cilia/ultrastructure ; Dishevelled Proteins ; Embryo, Mammalian/abnormalities ; Embryo, Mammalian/anatomy & histology ; Embryo, Mammalian/physiology ; Humans ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Nodal Protein/genetics ; Nodal Protein/metabolism ; Phosphoproteins/genetics ; Phosphoproteins/metabolism ; RNA Interference ; RNA-Binding Proteins ; Signal Transduction/physiology ; Wnt Proteins/genetics ; Wnt Proteins/metabolism ; Xenopus Proteins ; Xenopus laevis/anatomy & histology ; Xenopus laevis/embryology ; Xenopus laevis/genetics ; Xenopus laevis/metabolism
    Chemical Substances Adaptor Proteins, Signal Transducing ; Bicc1 protein, mouse ; Carrier Proteins ; DVL1 protein, Xenopus ; DVL2 protein, human ; Dishevelled Proteins ; Dvl2 protein, mouse ; Nodal Protein ; Nodal protein, mouse ; Phosphoproteins ; RNA-Binding Proteins ; Wnt Proteins ; Xenopus Proteins
    Language English
    Publishing date 2009-07-29
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 90607-4
    ISSN 1477-9129 ; 0950-1991
    ISSN (online) 1477-9129
    ISSN 0950-1991
    DOI 10.1242/dev.038174
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation.

    Guilleret, Isabelle / Yan, Pu / Guillou, Louis / Braunschweig, Richard / Coindre, Jean-Michel / Benhattar, Jean

    Carcinogenesis

    2002  Volume 23, Issue 12, Page(s) 2025–2030

    Abstract: Telomerase, the ribonucleoprotein complex involved in telomere maintenance, is composed of two main components: hTERT and hTERC. hTERT seems to be the rate-limiting factor for telomerase activity, although hTERC expression was also shown to correlate to ... ...

    Abstract Telomerase, the ribonucleoprotein complex involved in telomere maintenance, is composed of two main components: hTERT and hTERC. hTERT seems to be the rate-limiting factor for telomerase activity, although hTERC expression was also shown to correlate to a certain extent with telomerase reactivation. To determine whether the absence of hTERC expression could be the consequence of DNA methylation, we quantified hTERC RNA in 60 human samples (19 telomerase-negative normal tissues, nine telomerase-positive and 22 telomerase-negative tumor tissues, eight telomerase-positive and two telomerase-negative cell lines) using a quantitative dot blot on RT-PCR products. Most of the normal tissues did not express hTERC whereas, in telomerase-positive cell lines and in telomerase-positive tumor tissues, a strong up-regulation was observed, suggesting that hTERC transcription is up-regulated during tumorigenesis. The two telomerase-negative cell lines did not express hTERC. In a series of 22 telomerase-negative soft tissue sarcomas (STS), half did not express hTERC at all, or only weakly, whereas a wide range of expression was observed in the other half. As methylation might be involved in hTERC silencing, we examined the methylation pattern in all samples by direct sequencing and methylation-specific single stand conformation analysis after bisulfite modification. hTERC methylation was never observed, neither in normal nor in tumor tissues. Furthermore, there was no correlation between hTERC expression and proliferation, telomere length or hTERT expression in telomerase-negative STS. In contrast, three of eight telomerase-positive cell lines and the two telomerase negative cell lines were found to be hypermethylated, suggesting that the methylation observed may occur during cell line establishment. In conclusion, this study shows that hTERC expression is indeed regulated during carcinogenesis, but this regulation is unlikely to depend on hTERC methylation, cell proliferation rate, telomere length or hTERT expression.
    MeSH term(s) Antimetabolites, Antineoplastic/pharmacology ; Azacitidine/analogs & derivatives ; Azacitidine/pharmacology ; Cell Division ; Cell Line ; DNA Methylation ; Decitabine ; Gene Expression Regulation, Neoplastic ; HeLa Cells ; Humans ; Neoplasms/metabolism ; Polymorphism, Genetic ; Promoter Regions, Genetic ; Protein Conformation ; RNA/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Sarcoma/metabolism ; Sulfites/pharmacology ; Telomerase/metabolism ; Tumor Cells, Cultured
    Chemical Substances Antimetabolites, Antineoplastic ; Sulfites ; telomerase RNA ; RNA (63231-63-0) ; Decitabine (776B62CQ27) ; Telomerase (EC 2.7.7.49) ; Azacitidine (M801H13NRU)
    Language English
    Publishing date 2002-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603134-1
    ISSN 1460-2180 ; 0143-3334
    ISSN (online) 1460-2180
    ISSN 0143-3334
    DOI 10.1093/carcin/23.12.2025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top